Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,395 public trials 842 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

NCT02620800

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Tufts - New England Medical Center Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Karmanos Cancer Center Wayne State University Detroit, Michigan, United States
View Trial Details
Completed

Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

NCT00733746

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Kaiser Permanente Medical Center - Los Angeles Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States
  • St. Vincent's Medical Center Bridgeport, Connecticut, United States
View all 24 locations
View Trial Details
Completed

A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)

NCT03460990

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Yale New Haven Medical Center New Haven, Connecticut, United States
  • University of Miami/Miller School of Medicine Miami, Florida, United States
  • St. Luke's CF Center of Idaho Boise, Idaho, United States
View all 46 locations
View Trial Details
Completed

Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.

NCT02043730

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • A.O. Universitaria Ospedali Riuniti Ancona, AN, Italy
  • Istituto Tumori Giovanni Paolo II Bari, BA, Italy
  • A.O. Treviglio-Caravaggio, P.le Ospedale n1 Treviglio, Bergamo, Italy
  • A.O. Humanitas Gavazzeni Bergamo, BG, Italy
View all 39 locations
View Trial Details

Related conditions